Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua R Atkins

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Scientific Reports|January 23, 2020
Pharmacological enrichment of polygenic risk for precision medicine in complex disordersWilliam R Reay, Joshua R Atkins, Vaughan J Carr, et al.
Frontiers in Molecular Neuroscience|September 8, 2017
miRNA Enriched in Human Neuroblast Nuclei Bind the MAZ Transcription Factor and Their Precursors Contain the MAZ Consensus MotifBelinda J Goldie, Chantel Fitzsimmons, Judith Weidenhofer, et al.
Molecular Psychiatry|December 12, 2018
Polygenic disruption of retinoid signalling in schizophrenia and a severe cognitive deficit subtypeWilliam R Reay, Joshua R Atkins, Yann Quidé, et al.
American Journal of Human Genetics|September 2, 2022
Genetics-informed precision treatment formulation in schizophrenia and bipolar disorderWilliam R Reay, Michael P Geaghan, Joshua R Atkins, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 17, 2017
Common variation in ZNF804A (rs1344706) is not associated with brain morphometry in schizophrenia or healthy participantsYann Quidé, Natalie Matosin, Joshua R Atkins, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 21, 2019
Circular RNA biogenesis is decreased in postmortem cortical gray matter in schizophrenia and may alter the bioavailability of associated miRNAEbrahim Mahmoudi, Chantel Fitzsimmons, Michael P Geaghan, et al.
Clinical Nutrition (Edinburgh, Scotland)|September 5, 2025
The plasma proteome of plant-based diets: Analyses of 2920 proteins in 49,615 peopleTammy Y N Tong, Karl Smith-Byrne, Keren Papier, et al.
Journal of Psychiatric Research|March 15, 2019
Alteration of miRNA-mRNA interactions in lymphocytes of individuals with schizophreniaMichael P Geaghan, Joshua R Atkins, Alan M Brichta, et al.
Science Advances|April 6, 2022
Genetic estimates of correlation and causality between blood-based biomarkers and psychiatric disordersWilliam R Reay, Dylan J Kiltschewskij, Michael P Geaghan, et al.
Microarrays (Basel, Switzerland)|September 8, 2016
Advantages of Array-Based Technologies for Pre-Emptive Pharmacogenomics TestingAl Shahandeh, Daniel M Johnstone, Joshua R Atkins, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Scientific Reports|January 23, 2020
Pharmacological enrichment of polygenic risk for precision medicine in complex disordersWilliam R Reay, Joshua R Atkins, Vaughan J Carr, et al.
Frontiers in Molecular Neuroscience|September 8, 2017
miRNA Enriched in Human Neuroblast Nuclei Bind the MAZ Transcription Factor and Their Precursors Contain the MAZ Consensus MotifBelinda J Goldie, Chantel Fitzsimmons, Judith Weidenhofer, et al.
Molecular Psychiatry|December 12, 2018
Polygenic disruption of retinoid signalling in schizophrenia and a severe cognitive deficit subtypeWilliam R Reay, Joshua R Atkins, Yann Quidé, et al.
American Journal of Human Genetics|September 2, 2022
Genetics-informed precision treatment formulation in schizophrenia and bipolar disorderWilliam R Reay, Michael P Geaghan, Joshua R Atkins, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 17, 2017
Common variation in ZNF804A (rs1344706) is not associated with brain morphometry in schizophrenia or healthy participantsYann Quidé, Natalie Matosin, Joshua R Atkins, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 21, 2019
Circular RNA biogenesis is decreased in postmortem cortical gray matter in schizophrenia and may alter the bioavailability of associated miRNAEbrahim Mahmoudi, Chantel Fitzsimmons, Michael P Geaghan, et al.
Clinical Nutrition (Edinburgh, Scotland)|September 5, 2025
The plasma proteome of plant-based diets: Analyses of 2920 proteins in 49,615 peopleTammy Y N Tong, Karl Smith-Byrne, Keren Papier, et al.
Journal of Psychiatric Research|March 15, 2019
Alteration of miRNA-mRNA interactions in lymphocytes of individuals with schizophreniaMichael P Geaghan, Joshua R Atkins, Alan M Brichta, et al.
Science Advances|April 6, 2022
Genetic estimates of correlation and causality between blood-based biomarkers and psychiatric disordersWilliam R Reay, Dylan J Kiltschewskij, Michael P Geaghan, et al.
Microarrays (Basel, Switzerland)|September 8, 2016
Advantages of Array-Based Technologies for Pre-Emptive Pharmacogenomics TestingAl Shahandeh, Daniel M Johnstone, Joshua R Atkins, et al.
Pageof 3